Dermagnostix develops Molecular diagnostic systems for dermatologyThe platforms enable fast, objective and reproducible results. The platforms combine microfluidic technology with molecular analysis and complement traditional histological methods.

The innovation lies in the More precise differential diagnosis of skin diseasesThis enables treatment decisions to be made in a more informed and patient-centred way.